Herbert B. Newton, MD, FAAN Advent Health Cancer Institute
Advertisement
Articles by Herbert B. Newton, MD, FAAN Advent Health Cancer Institute
Advertisement
Latest Updated Articles
Overview of Plexiform Neurofibromas in NF1Published: March 23rd 2020 | Updated:
Treatment of NF1 With PNs: MEK InhibitionPublished: March 23rd 2020 | Updated:
Managing Symptoms of NF1Published: March 23rd 2020 | Updated:
Therapeutic Options for NF1 With PNsPublished: March 23rd 2020 | Updated:
Diagnosis of Neurofibromatosis Type 1Published: March 23rd 2020 | Updated:
Management of Plexiform Neurofibromas in NF1Published: March 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5